Department of Radiation Medicine & Applied Science - Open Access Policy Deposits

Parent: School of Medicine

eScholarship stats: Breakdown by Item for June through September, 2026

ItemTitleTotal requestsDownloadView-only%Dnld
5tx5x76fImmunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety81059121973.0%
8v30f9qzBreast Cancer Risk Genes — Association Analysis in More than 113,000 Women530434878.1%
2sm5p2fbRed Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer46035310776.7%
86c52204AAPM task group report 302: Surface‐guided radiotherapy4089031822.1%
2rr82304Non-invasive bladder function measures in healthy, asymptomatic female children and adolescents: A systematic review and meta-analysis3352439272.5%
64q353j6Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects32712120637.0%
1r05b09cSafety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.3226525720.2%
8zp2p19kDesign and Validation of Miniaturized Repetitive Transcranial Magnetic Stimulation (rTMS) Head Coils31614317345.3%
79w4r3qfThe tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy30713517244.0%
7861k3pcEmerging role of immunogenic cell death in cancer immunotherapy30313217143.6%
8xt673k7Global challenges of radiotherapy for the treatment of locally advanced cervical cancer2812305181.9%
00j856g9Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer2601897172.7%
8mn2q2crAdditional SNPs improve risk stratification of a polygenic hazard score for prostate cancer2521629064.3%
7bd8z06qThe renal clear cell carcinoma immune landscape2426517726.9%
8m76099gProton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee23711012746.4%
5n37184sThe Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)2273818916.7%
09z3n20nReproductive risk factors and breast cancer subtypes: a review of the literature2232819512.6%
36q7h95dGenome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses2216415729.0%
5df972fcClinical Guidelines for the Emergency Department Evaluation of Subarachnoid Hemorrhage22111710452.9%
501663s9Review of the medical and legal literature on restraint chairs2195416524.7%
2mg8p2dvHead and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.21711210551.6%
5fn033tgDopamine Dysregulation in Reward and Autism Spectrum Disorder.2101248659.0%
34974766Radiation-Induced Volume Changes in the Parotid and Submandibular Glands, Intra-Gland Dose Distribution, and Quality of Life Scores Over a Long Follow-Up Period2022917314.4%
6j76s343Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard Score2021643881.2%
73k820f8Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q242012817313.9%
6fh9b1p2African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer2001584279.0%
1175j88pRisk of Incident and Fatal Colorectal Cancer After Young-Onset Adenoma Diagnosis: A National Cohort Study1991376268.8%
9v72021h[18F]Fluoro-2-deoxy-2-d-glucose versus 3′-deoxy-3′-[18F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients1982017810.1%
66j3g23qMendelian randomisation study of smoking exposure in relation to breast cancer risk1962816814.3%
7009d51pCancer-related Emergency Department Visits: Comparing Characteristics and Outcomes1965414227.6%
4xs9q63gTargeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy1931009351.8%
6gh7s7srDevelopment of Conceptual Models to Guide Public Health Research, Practice, and Policy: Synthesizing Traditional and Contemporary Paradigms1937711639.9%
6gh2t3c7Protocol to study the immune profile of syngeneic mouse tumor models189929748.7%
0v47k6m8NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.184899548.4%
17f6g4ghOpioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates1824913326.9%
2jx5t1xhTreatment Landscape of Renal Cell Carcinoma1821057757.7%
7806p41zPhase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma182839945.6%
0p1312b0Characteristics and Outcomes of T1a Renal Cell Carcinoma Presenting with Metastasis1797510441.9%
9m38g641Abnormalities in hippocampal volume of glioma patients prior to radiotherapy1772615114.7%
6rq0c7z3The effect of sample size on polygenic hazard models for prostate cancer1752215312.6%
9x51g6ffThe Role of Optical Surface Imaging Systems in Radiation Therapy174948054.0%
3rh5061nHuman papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway1736910439.9%
74s5j6qcReview article: Lynch Syndrome—a mechanistic and clinical management update170977357.1%
2p59p3dbCharacterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants1661046262.7%
54r1d8c3Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability1665211431.3%
50d1541vFast and efficient QTL mapper for thousands of molecular phenotypes1644312126.2%
0g74s18qPersonalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veterans163748945.4%
8fj8q5j7Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis1611174472.7%
0kp9k26fAnalysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification1604111925.6%
18w5121sPolygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes1593312620.8%

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.